Zantac / Ranitidine (NDMA Cancer) Lawsuit in Louisiana

Time limits apply in Louisiana. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: March 2, 2026How we research

Last reviewed against primary sources: March 2, 2026

Statute of Limitations

Louisiana has a 1-year prescriptive period (statute of limitations) for delictual personal injury actions (La. Civ. Code art. 3492) — one of the two shortest limitation periods in the Zantac claimant pool alongside Tennessee. The discovery doctrine (contra non valentem) tolls the period until the claimant discovers the injury and its cause. Louisiana courts apply a Daubert-based standard for expert testimony under La. C.E. art. 702. Louisiana's 1-year deadline makes it one of the most time-sensitive states for Zantac cancer claimants — any delay risks permanent loss of claims.

1 year from date of cancer diagnosis discovery — MOST URGENT: act immediately (tied with Tennessee)

Louisiana Data

Exposure in Louisiana

Source: U.S. Census Bureau 2024

Source: Louisiana Tumor Registry 2024

Source: La. Civ. Code art. 3492

Medical Resources

Clinics & Specialists in Louisiana

LSU Health New Orleans — Feist-Weiller Cancer Center

Tulane Cancer Center